Cook Children’s Hospital in Texas acquires NBS System from Nexstim Plc

on 14/11/2016 10:20

Euroscreen announces name change to Ogeda and completion of Series B financing

on 19/10/2016 11:35
New identity reflects Ogeda’s successful transition to GPCR drug discovery & development
Read more

Nexstim Plc Key Technology Patent granted in EU

on 05/10/2016 10:29
Strengthened patent estate around Nexstim’s cutting-edge technology and software
Read more

Mainstay Medical announces Half Year Financial Results

on 22/09/2016 10:33

ReActiv8-A Clinical Trial – Sustained Performance at One Year

on 20/09/2016 10:37
One-year data confirm clinically important, statistically significant, and lasting improvement in pain, disability and quality of life for people with Chronic Low Back Pain and limited treatment options
Read more